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Abstract
Aims To assess the impact of educational attainment on the occurrence and recurrence of gestational diabetes mellitus 
(GDM) in two successive pregnancies in primiparous women.
Methods This is a population-based observational cohort study including all 2347 Finnish women without previously diag-
nosed diabetes, aged ≥ 20 years from the city of Vantaa, Finland, who gave birth to their first and second child between 2009 
and 2015. National registries provided data on study participants. We divided the population into four groups according to the 
presence of GDM in the two pregnancies (GDM−/−, n = 1820; GDM−/+, n = 223; GDM+/−, n = 113; GDM+/+, n = 191).
Results The occurrence of GDM in the first pregnancy was 13.0% (n = 304) and 17.6% (n = 414) in the second. The recur-
rence rate of GDM was 62.8%. The four groups did not differ in relation to educational attainment (p = 0.11). In multinomial 
regression analysis, educational attainment protected from GDM in the second pregnancy [relative risk ratio 0.93 (95% 
confidence interval (CI) 0.86–0.99) per year of schooling for being GDM−/+ compared with GDM−/−]. In multivariate 
logistics models, prepregnancy body mass index at the first pregnancy [odds ratio (OR) 1.53 per 1-standard deviation (SD) 
(95% CI 1.22–1.91)], first-born birth weight z-score [OR 1.30 per 1-SD (95% CI 1.00–1.67)], and inter-pregnancy weight 
change [OR 1.66 per 1-SD (95% CI 1.27–2.16)], but not educational attainment, predicted recurrence of GDM.
Conclusions The recurrence rate of GDM was high. Education protected from novel GDM in the second pregnancy, but was 
not associated with GDM recurrence.
Keywords Educational status · Maternal · Diabetes · Gestational · Pregnancy · Prevalence · Recurrence
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Introduction
Gestational diabetes mellitus (GDM) is a serious and 
increasing public health issue and a common pregnancy 
complication associated with adverse short- and long-term 
health outcomes for the woman and her offspring [1–3]. 
The incidence of GDM worldwide varies from 2 to 25% 
[4]. Noteworthy is that the recurrence of GDM is high and 
likewise varies widely from 30 to 84% [5].
Advancing age [6, 7], a family history of diabetes [7], 
and ethnicity of a non-Anglo-European decent [8] are 
well-established risk factors for GDM. Multiparity is also 
associated with an increased risk of GDM [6], although 
advancing maternal age and weight gain both during and 
between pregnancies seem to mediate the effect [9]. Addi-
tionally, both ethnicity and parity have a significant effect 
on the recurrence rate of GDM. The recurrence rates are 
lowest in primiparous women and in non-Hispanic whites, 
whereas the rates are highest in multiparous women and in 
women of other ethnicities [10]. Modifiable risk factors for 
the occurrence and recurrence of GDM are mostly lifestyle 
related, such as degree of adiposity [11, 12], excessive 
gestational weight gain [13], and inter-pregnancy weight 
gain [14, 15].
Higher educational attainment, reflecting the knowl-
edge-related assets of an individual [16], is usually asso-
ciated with better health outcomes in the general popula-
tion [17]. Findings concerning the impact of education 
on GDM risk are, however, inconclusive. Some studies 
have reported an inverse relationship between these two 
factors [18, 19], while the same relationship has not been 
observed in other studies [20, 21]. To the best of our 
knowledge, no previous studies have focused on educa-
tional attainment and the risk of occurrence and recurrence 
of GDM in European primiparous women.
In 2016, we initiated a follow-up cohort study to assess 
the long-term consequences of gestational glucose intoler-
ance on the health of women and their offspring in the city 
of Vantaa, Finland. We have previously shown that within 
this cohort, income and education are inversely associated 
with the occurrence of GDM in primiparous women [22]. 
This paper, assessing a subgroup from the prior study, 
aims to evaluate further the influence of maternal educa-
tional attainment on the presence of GDM in the first two 
pregnancies leading to delivery, also taking into account 
traditional risk factors like maternal age and adiposity for 
GDM.
Participants and methods
This study is an observational cohort study in the city of 
Vantaa, Finland. The city of Vantaa with 220 000 inhabit-
ants is the fourth largest city in Finland. The study par-
ticipants (N = 2347) consist of all those Finnish women 
(i.e., women born in Finland with Finnish or Swedish as 
native language), aged 20 years or older, from the city of 
Vantaa, who gave birth to their first and second live sin-
gleton child between the 1st of January 2009 and the 31st 
of December 2015. We excluded women with preexisting 
diabetes mellitus based on data obtained from the Finnish 
Social Insurance Institution.
The Finnish Medical Birth Register, maintained by 
the Finnish Institute for Health and Welfare, receives the 
information on all live births and stillbirths from 22 weeks 
of gestation or a birth weight of 500 g onward. From this 
source, we obtained data on deliveries, maternal age, 
GDM diagnoses, antenatal hospitalization due to hyperten-
sive disorders during pregnancy (including ICD-10 codes 
O10, O13, and O14), prepregnancy height and weight, 
number of previous pregnancies (including miscarriages, 
induced abortions, and ectopic pregnancies), smoking dur-
ing pregnancy, cohabitation status, and use of any infertil-
ity treatment [23]. We additionally collected supplemental 
data on missing information on GDM, height, and weight 
from individual patient healthcare records. We obtained 
data on educational attainment as years of schooling from 
Statistics Finland. Nine to ten years of school corresponds 
to basic (compulsory) education; 11–14 years of school 
corresponds to upper secondary education or post-second-
ary non-tertiary education; 15–16 years of school corre-
sponds to bachelor’s or equivalent education, and 17 years 
or more of school corresponds to master’s, doctoral, or 
equivalent education. The Finnish Tax Administration pro-
vided data on maternal annual taxable income before the 
first pregnancy.
In Finland, GDM is screened in public antenatal clin-
ics in primary healthcare centers according to the Finnish 
Current Care Guidelines for GDM [24]. Since 2008, GDM 
has been screened using a 75-g 2-h oral glucose tolerance 
test between 24 and 28 weeks of gestation in all preg-
nant women, with the exception of those who are at low 
risk, i.e., nulliparous women aged < 25 years, with a body 
mass index (BMI) 18.5–24.9 kg/m2, and without a first-
degree family history of diabetes; or multiparous women 
aged < 40 years, with a BMI < 25 kg/m2, and without 
prior GDM or previous offspring macrosomia. Women at 
the highest risk (e.g., with a BMI ≥ 35 kg/m2, prior GDM, 
glycosuria, first- or second-degree family member with 
type 2 diabetes, continuous use of oral corticosteroids, 
or polycystic ovary syndrome) are tested for the first time 
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already at 12–16 weeks of gestation, and if the results are 
negative, the test is repeated between 24 and 28 weeks of 
gestation. One or more pathological glucose value in the 
oral glucose tolerance test with the following diagnostic 
thresholds: fasting plasma glucose ≥ 5.3 mmol/L, 1-h glu-
cose ≥ 10.0 mmol/L, and 2-h glucose ≥ 8.6 mmol/L lead 
to a diagnosis of GDM.
We divided the study population into four groups accord-
ing to the occurrence of GDM in the first two pregnancies 
leading to delivery: no GDM (GDM−/−), GDM only in the 
second pregnancy (GDM−/+), GDM only in the first preg-
nancy (GDM+/−), or GDM in both pregnancies (GDM+/+) 
(Fig. 1).
Statistical analysis
Data are presented as means with standard deviations (SD) 
for continuous variables, or as counts with percentages for 
categorical variables. We compared differences of par-
ticipant characteristics between subgroups of participants 
(according to the occurrence of GDM in the two successive 
pregnancies) using analysis of variance (ANOVA), with 
Hommel’s multiple comparison procedure to correct sig-
nificance levels for post hoc testing. A multinomial logistic 
regression analysis was applied to assess the relative risk 
ratios (RRRs) of characteristics at the first pregnancy for 
the presence of GDM in the two successive pregnancies, 
with the women with no GDM (GDM−/−), as a reference 
group. A multivariate logistic regression model was used 
to examine the predictive odds ratios (OR) of participant 
characteristics on the risk of recurrence of GDM. Stata 15.1 
(StataCorp LP; College Station, Texas, USA) statistical 
package was used for the analyses.
Results
The mean age of the women in the study population at 
the time of the first delivery was 28.3 (SD 4.3) years. The 
mean length of education in the cohort was 13.8 (SD 2.5, 
range 9–22) years, and mean BMI before the first preg-
nancy 23.9 (SD 4.4) kg/m2. The correlation between length 
of education and BMI was − 0.04 (− 0.08 to − 0.01). The 
occurrence of GDM was 13.0% (n = 304) in the first preg-
nancy and 17.6% (n = 404) in the second pregnancy. The 
recurrence rate of GDM was 62.8% (n = 191/304). The 
mean interval between the two successive deliveries was 
2.4 (SD 0.9) years.
Table 1 presents the characteristics of the study par-
ticipants before their first pregnancy and between the two 
successive pregnancies according to the presence of GDM. 
Women in the GDM−/+ group gained 5.0 (SD 6.4) kg of 
weight between the two pregnancies, while the ones in the 
GDM+/− group lost 0.5 (SD 5.6) kg of weight between 
the two pregnancies (p < 0.001 between groups) (Table 1). 
The results concerning inter-pregnancy weight change 
remained the same after adjustments for the following 
characteristics at the first pregnancy: age, smoking, edu-
cational attainment, prepregnancy BMI, use of any fertility 
treatment, and hypertensive disorder during pregnancy.
In a multinomial logistic regression model, higher edu-
cational attainment decreased the relative risk ratio (RRR) 
for the presence/occurrence of GDM in the second preg-
nancy only (GDM−/+), when compared to women with 
no GDM (GDM−/−) (p = 0.016) (Table 2). A similar, but 
nonsignificant trend was seen in GDM+/− and GDM +/+ 
groups, with the GDM−/− group as reference.
In a multivariate logistic regression model, the inde-
pendent predictive factors for recurrence of GDM were 
prepregnancy BMI at the first pregnancy, birth weight 
z-score of the first child, and inter-pregnancy weight 
change (Fig. 2). The OR for recurrence of GDM was 1.53 
(95% CI 1.22–1.91]) for each 1-SD increase in prepreg-
nancy BMI at the first pregnancy, 1.30 (95% CI 1.00–1.67) 
for each 1-SD increase in birth weight z-score of the first 
child, and 1.66 (95% CI 1.27–2.16) for each 1-SD increase 
in weight change between pregnancies.
Fig. 1  Flowchart of the first and 
the second pregnancy of 2347 
Finnish primiparous women, 
aged 20 years or older, from the 
city of Vantaa, Finland, giving 
birth between 2009 and 2015, 
according to the occurrence of 
gestational diabetes (GDM)
GDM in first 
pregnancy
n=304
No GDM in first 
pregnancy
n=2043
Primiparous women
N=2347
No GDM in second 
pregnancy (GDM-/-)
n=1820
GDM in second 
pregnancy (GDM-/+)
n=223
No GDM in second 
pregnancy (GDM+/-)
n=113
GDM in second 
pregnancy (GDM+/+)
n=191
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Discussion
The occurrence of GDM in the first pregnancy was 13.0%, 
and 17.6% in the second pregnancy. The recurrence of GDM 
was high, 63%. We detected a trend of higher education pro-
tecting against the presence of GDM in either or both of the 
two successive pregnancies in our cohort of Finnish primipa-
rous women. The protective effect, however, was significant 
only when comparing women with GDM present only in the 
second pregnancy (GDM−/+) with women without GDM 
in neither of the pregnancies (GDM −/−). Maternal educa-
tional attainment did not, interestingly enough, influence the 
recurrence of GDM. Independent predictors of recurrence of 
GDM were BMI before the first pregnancy, birth weight of 
the first child, and inter-pregnancy weight change.
Our study has several strengths: The study cohort is 
comprehensive; all Finnish women from the city of Vantaa, 
aged 20 years or older, without preexisting diabetes, and 
who delivered for the first and second time during a 7-year 
study period, were included in the study. We included only 
Table 1  Participant characteristics of 2347 Finnish primiparous women, aged 20 years or more, and without previously diagnosed diabetes mel-
litus, according to the occurrence of gestational diabetes (GDM) in two successive pregnancies
a Hommel’s multiple comparison procedure was used to correct significance levels for post hoc testing (p < 0.05)
b Miscarriages, induced abortions, and ectopic pregnancies
c Antenatal hospitalization with ICD-10 codes O10, O13, or O14
No GDM in first pregnancy GDM in first pregnancy
No GDM in 
second pregnancy 
(GDM−/−)
N = 1820
GDM in sec-
ond pregnancy 
(GDM−/+)
N = 223
No GDM in 
second pregnancy 
(GDM+/−)
N = 113
GDM in sec-
ond pregnancy 
(GDM+/+)
N = 191
p value between groups 
(multiple comparison)a
Characteristics at first pregnancy
Age (years), mean (SD) 28.1 (4.3) 28.7 (4.1) 28.5 (4.3) 29.3 (4.2) 0.003 [1/4]
Cohabiting, n (%) 1510 (83) 197 (88) 96 (85) 159 (83) 0.23
Smokers, n (%) 255 (14) 41 (18) 22 (19) 32 (17) 0.13
Years of schooling, mean 
(SD)
13.9 (2.5) 13.5 (2.5) 13.5 (2.4) 13.7 (2.4) 0.11
Annual income (1000 
EUR), mean (SD)
26.9 (12.9) 26.6 (11.7) 26.8 (12.7) 27.1 (13.1) 0.96
Height (cm), mean (SD) 166 (6) 165 (6) 165 (6) 165 (6) 0.22
Weight (kg), mean (SD) 64 (12) 70 (14) 69 (14) 76 (17) < 0.001 [1/2, 1/3, 1/4, 2/4, 
3/4]
Prepregnancy BMI (kg/
m2), mean (SD)
23.2 (3.8) 25.3 (4.6) 25.3 (5.1) 27.7 (5.6) < 0.001 [1/2, 1/3, 1/4, 2/4, 
3/4]
Prepregnancy obesity 
(BMI ≥30 kg/m2), n 
(%)
114 (6) 35 (16) 20 (18) 62 (32) < 0.001 [1/2, 1/3, 1/4, 2/4, 
3/4]
Previous  pregnanciesb, 
n (%)
0.86
 None 1494 (82) 180 (81) 87 (77) 155 (81)
 1 237 (13) 29 (13) 19 (17) 26 (14)
 ≥2 89 (5) 14 (6) 7 (6) 10 (5)
Any fertility treatment, 
n (%)
127 (7) 19 (9) 16 (14) 25 (13) 0.002 [1/3, 1/4]
Hypertensive disorder of 
 pregnancyc, n (%)
88 (5) 11 (5) 9 (8) 21 (11) 0.003 [1/4]
Birth weight (z-score), 
mean (SD)
− 0,06 (0,97) 0,23 (1,03) − 0,06 (1,11) 0,31 (1,07) 0.001 [1/2 1/4, 2/3,4/3]
Characteristics between pregnancies
Weight change between 
pregnancies (kg), mean 
(SD)
1.4 (5.0) 5.0 (6.4) − 0.5 (5.6) 2.2 (6.3) < 0.001 [1/2, 1/3, 2/3, 2/4, 
3/4]
Time between deliveries 
(years), mean (SD)
2.4 (0.9) 2.5 (1.0) 2.3 (0.9) 2.4 (1.1) 0.53
1039Acta Diabetologica (2020) 57:1035–1042 
1 3
primiparous women to exclude the confounding effects of 
previous GDM or parity on the risk of GDM. The quality of 
the Finnish Medical Birth Register is considered good [25], 
and individual patient healthcare records provided an addi-
tional supplement for missing data. The national diagnostic 
criteria for GDM remained the same during the whole study 
period and are based on a 75-g standard 2-h oral glucose 
tolerance test. Further, educational attainment and annual 
maternal taxable income were not self-reported, rather based 
on data obtained from Statistics Finland and The Finnish 
Tax Administration, respectively.
Our study also has some limitations, including the lack of 
some well-known risk factors for GDM such as family his-
tory of diabetes and gestational weight gain. Furthermore, 
some of the women may have had an unrecognized diabe-
tes before or between the pregnancies and might have been 
misclassified as having GDM. As this is an observational 
register-based cohort study, we also lack data on lifestyle-
related factors including diet, physical activity, and sleep-
ing patterns. Lastly, the study participants were all Finnish 
women, mainly of European ancestry, limiting the generali-
zation of the results globally.
The occurrence of GDM in our cohort is in line with 
the nationwide Finnish occurrence, including all women 
regardless of parity, that increased from 9 to 16% during 
the study period between 2009 and 2016 [23]. The recur-
rence rate of over 60% of GDM can be considered high—
especially as non-Hispanic whites (recurrence rate of 35% 
compared with 56% in other ethnicities), and primiparous 
women (recurrence rate of 40% compared with 73% in mul-
tiparous women) are regarded as having the lowest risk of 
recurrence [10]. Most studies have reported lower recurrence 
rates (38–47%) of GDM in general [14, 26–29]. Dispari-
ties between study populations including ethnicity, genetic 
predisposition to both T2D and GDM, and the screening 
methods and diagnostic criteria for GDM can probably 
explain the varying observations regarding recurrence rates 
of GDM. Further, the number of prior pregnancies com-
plicated by GDM has an impact on the GDM recurrence. 
According to a Canadian study, women who had GDM in 
an index pregnancy had a recurrence rate of GDM of 72% 
in the second subsequent pregnancy, if the first subsequent 
pregnancy was also affected [30]. If the first subsequent 
pregnancy was not affected by GDM, the recurrence rate in 
the second subsequent pregnancy was only 22% [30].
In our study cohort, there was a trend of education hav-
ing a protective effect on GDM. The finding was, however, 
significant only when comparing women with GDM only 
in the second pregnancy (GDM−/+) with women without 
Table 2  Relative risk ratio (RRR)a of patient characteristics at the first pregnancy to predict risk of gestational diabetes (GDM) only in the first 
pregnancy, only in the second pregnancy, and in both pregnancies
a Multinominal logistic regression model was used to assess the RRR 
b Women having GDM in neither pregnancy (GDM−/−; n = 1820) are the reference group for the model
c Hypertensive disorder in the first pregnancy (antenatal hospitalization with ICD-10 codes O10, O13, and O14)
Occurrence of gestational diabetes
Only 1st  pregnancyb (GDM+/−)
N = 113
Only 2nd  pregnancyb (GDM−/+)
N = 223
Both  pregnanciesb 
(GDM+/+)
N = 191
RRR (95% CI) p value RRR (95% CI) p value RRR (95% CI) p value
Age 1.03 (0.98–1.09) 0.21 1.06 (1.02–1.10) 0.004 1.07 (1.03–1.12) < 0.001
Cohabiting 1.18 (0.69–2.03) 0.54 1.57 (1.02–2.44) 0.041 0.90 (0.59–1.38) 0.64
Smoking 1.40 (0.86–2.46) 0.17 1.40 (0.94–2.08) 0.98 1.24 (0.79–1.96) 0.35
Years of schooling 0.93 (0.85–1.03) 0.12 0.92 (0.86–0.99) 0.016 0.95 (0.89–1.03) 0.22
BMI (kg/m2) 1.12 (1.07–1.16) < 0.001 1.12 (1.08–1.15) < 0.001 1.21 (1.17–1.24) < 0.001
Any fertility treatment 2.34 (1.31–4.18) 0.004 1.25 (0.74–2.10) 0.40 2.04 (1.24–3.34) 0.005
Hypertensive  disorderc – – 0.83 (0.43–1.59) 0.57 1.75 (1.02–3.02) 0.043
Fig. 2  Risk of recurrence of gestational diabetes according to partici-
pant characteristics at the first pregnancy (prepregnancy body mass 
index [BMI], birth weight of the first child, maternal age at deliv-
ery, years of schooling, and *antenatal hospitalization in the first 
pregnancy due to hypertension [ICD-10 codes O10, O13, and O14], 
and smoking) and between pregnancies (weight change, and time as 
years). Multivariate logistic regression model was used to assess the 
risk
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GDM in neither pregnancy (GDM−/−). In our prior 
study, including a larger cohort of primiparous women, 
incidence of GDM showed an inverse association with 
educational attainment [22]. Further, there was no asso-
ciation between educational attainment and recurrence of 
GDM in the current study. Although some prior studies, 
including both primiparous and multiparous women, have 
found low-educated women having a higher risk of GDM 
than high-educated women [18, 19, 22]. However, in some 
other studies, no such association between education and 
risk of GDM has been detected [20, 21]. The use of vari-
ous criteria for educational attainment, as well as sample 
size and other factors related to study design, might at 
least partly explain these conflicting findings. Even less is 
known of the impact of education on the risk of recurrence 
of GDM [29, 31].
GDM is a heterogeneous disease with several underlying 
causes such as inadequate insulin secretion from pancreatic 
β-cells, insulin resistance, and genetic susceptibility [32, 33]. 
The dysfunction of pancreatic β-cells is probably not limited 
only to pregnancy, as it is also evident before pregnancy and 
during the postpartum period. Women who develop GDM 
seem additionally to be more insulin resistant already before 
pregnancy [34, 35]. These factors may at least partly explain 
the high recurrence of GDM [32, 36, 37]. Factors increas-
ing insulin resistance include high childbearing age, chronic 
low-grade inflammation due to obesity-induced lipid accu-
mulation, and insulin-desensitizing effects of the hormonal 
products of the placenta [37, 38].
Both a higher BMI and an advancing maternal age are 
traditional recognized risk factors for occurrence of GDM 
[6, 39]. In our cohort, a higher prepregnancy BMI predicted 
GDM in either pregnancy, or in both of them, compared 
with women who did not develop GDM at all. Our find-
ing of an increasing BMI having an independent predictive 
value for GDM recurrence is also supported by findings in 
the literature [40]. Both a higher maternal BMI at the index 
pregnancy [11, 12, 41] and an increase in weight before the 
subsequent pregnancy [30] are previously recognized risk 
factors for GDM recurrence.
Our observation that inter-pregnancy weight gain indepen-
dently increases the risk of GDM recurrence is also in line 
with several other studies [11, 12, 15, 28, 42]. In a meta-anal-
ysis by Schwartz and colleagues, weight gain between preg-
nancies was reported to have the largest effect size of studied 
risk factors for GDM recurrence [40]. Weight gain between 
pregnancies increases the level of insulin resistance, which, in 
turn, may contribute to β-cell exhaustion and thus, elevate the 
risk of GDM in the subsequent pregnancy [5, 14]. Weight loss 
between pregnancies may improve insulin sensitivity as well 
as β-cell function and thus, decrease the risk of GDM in the 
subsequent pregnancy [14]. According to a large cohort study 
in the USA, a decrease in BMI between pregnancies may act 
as a protective factor for GDM especially in overweight and 
obese women [14].
Prior infant birth weight [30], macrosomia [29], and LGA 
offspring [27, 41] have been shown to be predictive for recur-
rence of GDM in some studies. Our observation concern-
ing the association of birth weight of the first child and risk 
of GDM in the subsequent pregnancy is in line with these 
findings.
Prior findings in the literature additionally suggest advanc-
ing age being a risk factor for GDM recurrence [11, 27]. In our 
cohort, the age of the mother had, however, no independent 
predictive role for the recurrence. Compared with women who 
did not develop GDM in either pregnancy, advancing age did 
only predict the occurrence of GDM in the second pregnancy, 
independent of having GDM in the first pregnancy. According 
to some former findings, both shorter [12, 29] and longer [26, 
27] inter-pregnancy intervals have shown an association with 
an increased risk of GDM recurrence. We did, nonetheless, 
observe no such association in our study population, which is 
in line with a recent meta-analysis [40].
Although hypertensive disorders in the index pregnancy 
have also been associated with an increased risk of GDM 
recurrence [27], we did not detect such an association in our 
study. The sample size in our study population was, however, 
rather small to assess the impact of hypertensive disorders, as 
displayed by large confidence intervals in the model.
According to the findings in our cohort, use of infertil-
ity treatment was more common in the first pregnancy for 
women who also developed GDM in the same pregnancy 
(GDM+/− and GDM+/+), compared with women who did 
not develop GDM in either pregnancy (GDM−/−). The find-
ing is not surprising, as the risk of GDM has been shown to be 
increased in pregnancies with assisted reproduction technol-
ogy treatments [43].
GDM and its recurrence are serious public health con-
cerns that have implications for the health of women and 
their offspring over generations. Recurrence of GDM seems 
to increase the risk of developing diabetes later in life [44], 
but otherwise little is known about the impact of recurrence 
of GDM on maternal long-term health [45]. The healthcare 
system should ideally identify women with elevated risk of 
GDM already before their first pregnancy, as many of the fac-
tors such as an underlying insulin resistance and a dysfunction 
of pancreatic β-cells that might lead to development of GDM, 
exist already before conception. Further studies are required in 
order to evaluate how to reduce the risk of GDM recurrence.
Conclusion
According to our study findings, education protects from a 
novel occurrence of GDM in the second pregnancy, when 
the first pregnancy has not been complicated by GDM. 
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Maternal educational attainment seems to have no associa-
tion, however, with the risk of GDM recurrence. Overall, the 
recurrence of GDM was high in our cohort. Our results sug-
gest that maternal inter-pregnancy weight gain and a higher 
BMI before the first pregnancy, both factors being lifestyle 
related and modifiable, are the most important independent 
predictors for GDM recurrence in primiparous women.
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